Information Provided By:
Fly News Breaks for April 11, 2019
EVH
Apr 11, 2019 | 08:19 EDT
Passport Health Plan is "cautiously optimistic" that it will be able to remain in business in Kentucky after receiving an estimated 4.7% rate increase in its regions, Cowen analyst Charles Rhyee tells investors in a research note. He says this should remove a near-term overhang for Evolent Health, giving him confidence in the company's revenue outlook. The analyst, who maintains an Outperform rating and $26 price target on Evolent, believes the mid-high end of revenue and adjusted EBITDA guidance is now more achievable.